» Articles » PMID: 12973300

Directed Expression of the HIV-1 Accessory Protein Vpu in Drosophila Fat-body Cells Inhibits Toll-dependent Immune Responses

Overview
Journal EMBO Rep
Specialty Molecular Biology
Date 2003 Sep 16
PMID 12973300
Citations 27
Authors
Affiliations
Soon will be listed here.
Abstract

Human immunodeficiency virus 1 (HIV-1) expresses several accessory proteins that manipulate various host-cell processes to achieve optimum replicative efficiency. One of them, viral protein U (Vpu), has been shown to interfere with the cellular degradation machinery through interaction with SCF(beta-TrCP) complexes. To learn more about Vpu function in vivo, we used the genetically tractable fruit fly, Drosophila melanogaster. Our results show that the directed expression of Vpu, but not the non-phosphorylated form, Vpu2/6, in fat-body cells affects Drosophila antimicrobial responses. In flies, the Toll and Imd pathways regulate antimicrobial-peptide gene expression. We show that Vpu specifically affects Toll pathway activation by inhibiting Cactus degradation. Given the conservation of the Toll/nuclear factor-kappa B (NF-kappa B) signalling pathways between flies and mammals, our results suggest a function for Vpu in the inhibition of host NF-kappa B-mediated innate immune defences and provide a powerful genetic approach for studying Vpu inhibition of NF-kappa B signalling in vivo.

Citing Articles

A Drosophila model of HPV16-induced cancer reveals conserved disease mechanism.

Hashemi L, Ormsbee M, Patel P, Nielson J, Ahlander J, Barmchi M PLoS One. 2022; 17(12):e0278058.

PMID: 36508448 PMC: 9744332. DOI: 10.1371/journal.pone.0278058.


Drosophila as a Model for Human Viral Neuroinfections.

Benoit I, Di Curzio D, Civetta A, Douville R Cells. 2022; 11(17).

PMID: 36078091 PMC: 9454636. DOI: 10.3390/cells11172685.


The potential use of as an in vivo model organism for COVID-19-related research: a review.

Demir E Turk J Biol. 2021; 45(4):559-569.

PMID: 34803454 PMC: 8573831. DOI: 10.3906/biy-2104-26.


as a Model for Infectious Diseases.

Harnish J, Link N, Yamamoto S Int J Mol Sci. 2021; 22(5).

PMID: 33800390 PMC: 7962867. DOI: 10.3390/ijms22052724.


Potential Application of as a Model Organism in COVID-19-Related Research.

Nainu F, Rahmatika D, Emran T, Harapan H Front Pharmacol. 2020; 11:588561.

PMID: 33013425 PMC: 7500409. DOI: 10.3389/fphar.2020.588561.


References
1.
Karin M, Ben-Neriah Y . Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol. 2000; 18:621-63. DOI: 10.1146/annurev.immunol.18.1.621. View

2.
Tauszig S, Jouanguy E, Hoffmann J, Imler J . Toll-related receptors and the control of antimicrobial peptide expression in Drosophila. Proc Natl Acad Sci U S A. 2000; 97(19):10520-5. PMC: 27057. DOI: 10.1073/pnas.180130797. View

3.
Silverman N, Zhou R, Stoven S, Pandey N, Hultmark D, Maniatis T . A Drosophila IkappaB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 2000; 14(19):2461-71. PMC: 316979. DOI: 10.1101/gad.817800. View

4.
Heissmeyer V, Krappmann D, Hatada E, Scheidereit C . Shared pathways of IkappaB kinase-induced SCF(betaTrCP)-mediated ubiquitination and degradation for the NF-kappaB precursor p105 and IkappaBalpha. Mol Cell Biol. 2001; 21(4):1024-35. PMC: 99557. DOI: 10.1128/MCB.21.4.1024-1035.2001. View

5.
Stoven S, Ando I, Kadalayil L, Engstrom Y, Hultmark D . Activation of the Drosophila NF-kappaB factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 2001; 1(4):347-52. PMC: 1083746. DOI: 10.1093/embo-reports/kvd072. View